Rallybio
Price & Volume
Stats
See more52W Range | $0.22-$1.24 |
Market Cap | $24.4M |
Shares Short | 612,420 |
Financials
See moreRevenue (12 Mos) | $761,000 |
Revenue Growth (YoY) | -29.1% |
Gross Profit (12 Mos) | -$38.6M |
Diluted EPS | -$0.93 |
News
See moreYahoo Finance • 2 months ago
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 3 months ago
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
Yahoo Finance • 3 months ago
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Yahoo Finance • 3 years ago
5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
About
CEO | Dr. Stephen Uden M.B, M.D. |
CFO | Mr. Jonathan I. Lieber M.B.A. |
Address | 234 Church Street, New Haven, CT, United States, 06510 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
